Vera Therapeutics appoints Kimball Hall to board of directors

Vera Therapeutics, Inc.

Kimball Hall appointed to Board effective December 10, 2021 as Class I director.
Granted stock option for 19,850 shares vesting monthly over 3 years.
Annual cash retainer of $35,000, pro-rated for 2021.
Eligible for annual option grant of 9,925 shares starting 2022 annual meeting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kimball Hall

Director

VERA · Vera Therapeutics, Inc.

Effective: 2021-12-10
Filed: December 15, 2021, 6:59 PM ET

On December 10, 2021, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Kimball Hall to the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kimball Hall was appointed as Director at Vera Therapeutics, Inc..

Action: appointed
Role: Director

Exact text from the filing

On December 10, 2021, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Kimball Hall to the Board, effective immediately.

View on SEC.gov

Vera Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-357463

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.